Sharma, D.; Rasool, F.; Bharti, M.; Vyas, K.M.; Magani, S.K.J.
Regorafenib and Ruthenium Complex Combination Inhibit Cancer Cell Growth by Targeting PI3K/AKT/ERK Signalling in Colorectal Cancer Cells. Int. J. Mol. Sci. 2023, 24, 686.
https://doi.org/10.3390/ijms24010686
AMA Style
Sharma D, Rasool F, Bharti M, Vyas KM, Magani SKJ.
Regorafenib and Ruthenium Complex Combination Inhibit Cancer Cell Growth by Targeting PI3K/AKT/ERK Signalling in Colorectal Cancer Cells. International Journal of Molecular Sciences. 2023; 24(1):686.
https://doi.org/10.3390/ijms24010686
Chicago/Turabian Style
Sharma, Deepu, Fayyaz Rasool, Manjri Bharti, Komal M. Vyas, and Sri Krishna Jayadev Magani.
2023. "Regorafenib and Ruthenium Complex Combination Inhibit Cancer Cell Growth by Targeting PI3K/AKT/ERK Signalling in Colorectal Cancer Cells" International Journal of Molecular Sciences 24, no. 1: 686.
https://doi.org/10.3390/ijms24010686
APA Style
Sharma, D., Rasool, F., Bharti, M., Vyas, K. M., & Magani, S. K. J.
(2023). Regorafenib and Ruthenium Complex Combination Inhibit Cancer Cell Growth by Targeting PI3K/AKT/ERK Signalling in Colorectal Cancer Cells. International Journal of Molecular Sciences, 24(1), 686.
https://doi.org/10.3390/ijms24010686